1. New Diagnostic Tools: Relevance to Programs
Gail Bolan MD
Chief, STD Control Branch

2. HPV DNA Testing Benefit: to reduce colposcopy
CDC guidelines recommend triage of ASCUS Pap smear
Lack of programmatic capacity to perform quality Pap smears
Prevalence of HPV, ASCUS and HSIL unknown in most program settings

3. HSV Type Specific Serologic Testing
Benefit:
Decrease HSV Transmission
Impact of serostatus knowledge on condom use and psychological health
Decrease HIV Transmission
Role of asymptomatic HSV in HIV transmission
Prevent Neonatal HSV
Risk of increasing unnecessary C-sections

4. HSV Type Specific Serology
Test performance characteristics in the real world
QA programs especially in clinic settings
Role of confirmatory testing in low prevalence populations

5. Trichomoniasis Benefit: ???
Role of more expensive testing versus empiric treatment

6. Programmatic Barriers
No clear clinical guidelines
Limited cost benefit studies using programmatic data
Resources, Resources, Resources